Identification of nine genomic regions of amplification in urothelial carcinoma, correlation with stage, and potential prognostic and therapeutic value.
about
Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicityChromosomal imbalances in human bladder urothelial carcinoma: similarities and differences between biopsy samples and cancer stem-like cellsCombined CDKN1A/TP53 mutation in bladder cancer is a therapeutic target.Cross-laboratory validation of the OncoScan® FFPE Assay, a multiplex tool for whole genome tumour profiling.Canine urothelial carcinoma: genomically aberrant and comparatively relevant.Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma.Detection of specific chromosomal aberrations in urine using BCA-1 (oligo-CGH-array) enhances diagnostic sensitivity and predicts the aggressiveness of non-muscle-invasive bladder transitional cell carcinoma.Emerging drugs for urothelial carcinoma.Genomic characterization of three urinary bladder cancer cell lines: understanding genomic types of urinary bladder cancer.Effect of miR-29b-1* and miR-29c knockdown on cell growth of the bladder cancer cell line T24.Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA.Unwrapping the genomic characteristics of urothelial bladder cancer and successes with immune checkpoint blockade therapy.Detection of Bladder Cancer in Urine Sediments by a Novel Multicolor Fluorescence In Situ Hybridization (Quartet) Test.Fibroblast growth factor receptor (FGFR) gene amplifications are rare events in bladder cancer.
P2860
Q33729078-CA8E71C4-37DE-4A62-8CAE-B6B45CF8A8DEQ34174124-A58E9456-C357-4232-9297-3B4D2CFFEAE3Q34978486-6E169241-59D5-4E6F-B507-962D58EC9117Q35127769-ECD0E0A4-7C54-4318-BDA9-52225E098ADDQ35848084-E090D246-0CDA-4869-8202-B3FB9FD97E02Q36743446-4D72574E-07CD-4382-A887-601BF62E8CD9Q37653128-87C5243C-7DAE-40ED-9A57-9C1091A77AD9Q38160271-B269A546-8CD2-4015-A1E7-F785438E68A5Q39031180-2A07D168-86E7-41E5-A99C-01B44B3923A5Q39058458-E82D6384-9EA5-4A9F-9DF2-6AB31A0AD8E7Q40116927-32AC7CF7-04B4-4904-A348-F87FD3E15E9EQ49865882-85DCFF67-E8FC-4F91-8A02-E5E559C3EF2AQ50082421-26A7F17A-1FF5-4692-9325-CB139A9FA78DQ54347333-DE7AFD0C-0133-42A9-85C5-CD947047B570
P2860
Identification of nine genomic regions of amplification in urothelial carcinoma, correlation with stage, and potential prognostic and therapeutic value.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Identification of nine genomic ...... gnostic and therapeutic value.
@ast
Identification of nine genomic ...... gnostic and therapeutic value.
@en
Identification of nine genomic ...... gnostic and therapeutic value.
@nl
type
label
Identification of nine genomic ...... gnostic and therapeutic value.
@ast
Identification of nine genomic ...... gnostic and therapeutic value.
@en
Identification of nine genomic ...... gnostic and therapeutic value.
@nl
prefLabel
Identification of nine genomic ...... gnostic and therapeutic value.
@ast
Identification of nine genomic ...... gnostic and therapeutic value.
@en
Identification of nine genomic ...... gnostic and therapeutic value.
@nl
P2093
P2860
P1433
P1476
Identification of nine genomic ...... ognostic and therapeutic value
@en
P2093
Chin-Lee Wu
David J Kwiatkowski
Qishan Dai
Sharron Lin
W Scott McDougal
Yvonne Chekaluk
P2860
P304
P356
10.1371/JOURNAL.PONE.0060927
P407
P577
2013-04-04T00:00:00Z